4.6 Article

Prostate-Specific Antigen Doubling Time Kinetics following Radical Prostatectomy to Guide Need for Treatment Intervention: Validation of Low-Risk Recurrences

Related references

Note: Only part of the references are listed.
Review Urology & Nephrology

EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

Nicolas Mottet et al.

Summary: The 2020 EAU-EANM-ESTRO-ESUR-SIOG guidelines on screening, diagnosis, and treatment of localized prostate cancer summarize the most recent recommendations for clinical practice, including risk-adapted strategies, medical imaging utilization, biopsy techniques, patient classification, and treatment options. Recommendations include consideration of moderate hypofractionation for intermediate-risk patients and a combination of local treatment with long-term hormonal therapy for cN1 PCa patients.

EUROPEAN UROLOGY (2021)

Review Urology & Nephrology

Biochemical recurrence after radical prostatectomy: what does it mean?

Rafael Tourinho-Barbosa et al.

INTERNATIONAL BRAZ J UROL (2018)

Article Urology & Nephrology

Predicting 15-Year Prostate Cancer Specific Mortality After Radical Prostatectomy

Scott E. Eggener et al.

JOURNAL OF UROLOGY (2011)

Article Medicine, General & Internal

Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy

SJ Freedland et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)

Article Oncology

Long-term outcome of detectable PSA levels after radical prostatectomy

TE Ahlering et al.

PROSTATE CANCER AND PROSTATIC DISEASES (2005)

Article Oncology

Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy

AV D'Amico et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)